focus -WSS

focus

author：knowledge 2025-09-30 01:19:30 - browse：691

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Breakthrough Alzheimer’s drugs are inaccessible in rural states

focus

hotspot

WSS

Pence says 'crackpot lawyers' told Trump what he wanted to hear

What to expect as Trump is arraigned on his Jan 6. indictment

Involuntary treatment for addiction doesn't work

Mega Millions pot grows to $1.25 billion after no winner

Adults seen as increasingly susceptible to measles

Everything to know for the next Powerball drawing as jackpot hits $1 billion

hotspot

focus

focus

Anesthesiologist group: stop taking Ozempic before surgery

The high personal cost of affirmative action for Black doctors

Sports medicine is finally prioritizing gender equality

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Anesthesiologist group: stop taking Ozempic before surgery

Involuntary treatment for addiction doesn't work

Psychedelics group wrestles with new pharma identity

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

Dobbs anniversary: the lost opportunity of abortion as health care

‘Oppenheimer’ and the risks of AI in health care

Wikipedia

Physician groups backed by private equity giant lobby on mergers

‘Oppenheimer’ and the risks of AI in health care

Blood tests recalled over risk of missed heart attack diagnosis

Amazon expands telehealth clinic nationwide

Physician groups backed by private equity giant lobby on mergers

No plane should take off without an EpiPen onboard

entertainment

focus

hotspot

hotspot